CLASS II ONGOING Device recall · Reported 3 Dec 2025 · FDA Enforcement Report

BioFire Respiratory Panel 1, IVD recalled by BioFire Diagnostics

BioFire Diagnostics is recalling BioFire Respiratory Panel 1, IVD, distributed in 10 states. The recall was initiated on 22 Oct 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: 00815381020529 /Lot # 2649724 Expanded Lot#: 1471725
Quantity recalled97 Kits (2,910 pouches)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0602-2026
FDA event ID
97870
Recalling firm
BioFire Diagnostics, Salt Lake City, UT
Classification
Class II
Status
Ongoing
Recall initiated
22 Oct 2025
FDA classified
26 Nov 2025
Reported
3 Dec 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

22 Oct 2025Recall initiated by company
26 Nov 2025Classified by FDA+35 days
3 Dec 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)

Where it was distributed

US:AZ, FL,GA,ID NC, NH, NJ, NY, OR, PA, SC OUS: None

ArizonaFloridaGeorgiaNorth CarolinaNew HampshireNew JerseyNew YorkOregonPennsylvaniaSouth Carolina

Questions about this recall

Is BioFire Respiratory Panel 1, IVD recalled?

Yes. BioFire Diagnostics recalled BioFire Respiratory Panel 1, IVD on 22 Oct 2025. The recall is Class II and its status is Ongoing. Recall number Z-0602-2026.

Why was it recalled?

Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures.

Which lots are affected?

UDI: 00815381020529 /Lot # 2649724 Expanded Lot#: 1471725

Where was it sold?

US:AZ, FL,GA,ID NC, NH, NJ, NY, OR, PA, SC OUS: None

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from BioFire Diagnostics

All 44

Other CPAP & Ventilators recalls

All 552